Navigation Links
Blood test may aid foretell Alzheimer's

According to study in University of Texas, a novel blood test can detect plaque buildup in mice brains, suggesting a possible new way to predict who might get Alzheimer's disease.Researchers at the School of Medicine in St. Louis said it is unclear whether a similar blood test would work in people, but the findings in the animal studies appeared promising.//

Plaque buildup ruins brain cells and is the cause of Alzheimer's. Some people have a genetic propensity to develop this plaque later in life. The St. Louis team examined 40 mice carrying a genetic mutation to develop buildup up amyloid plaque. Two types of this amyloid protein were measured in the mice's blood. Animals then were injected with an antibody -- an immune system substance that fights infection -- called m266 -- which draws amyloid protein from the brain into the blood.

Within five minutes of the m266 injection, amyloid levels increased dramatically in the blood, indicating how much amyloid protein had built up in the mouse's brain. "That's like unbelievably fast," researcher Dr. David M. Holtzman told United Press International. "We thought if you saw anything it would take days."

The mice's brains were studied 24 hours after injection to affirm whether the levels detected in the blood had accurately reflected how much amyloid protein had built up in the brain tissue. The m266 injection appeared give an accurate picture.

"If this worked the same way in humans, it has the potential to be a predictor on who might develop Alzheimer's later," Holtzman added. M266 is a mouse antibody, Holtzman cautioned, so whether a similar human antibody exists to draw this plaque from the brain into the blood in people remains untested.

It is estimated 4 million Americans have Alzheimer's disease and that figure is expected to double in coming decades as more people live longer, though Holtzman said, "I think that's a big under-estimate," because it doesn't includ e folks with mild dementia.

Alzheimer's is a difficult disease to detect and doctors usually are not able to diagnose it or treat symptoms until the condition has progressed into more advanced stages. There is no cure for Alzheimer's but scientists are interested in an early screening test because earlier detection could mean starting treatment before symptoms -- such as forgetfulness, disorientation and dementia -- become unbearable.

"There's a tremendous ethical question for diagnosing (early) a disease for which this is no cure," James L. Olds, a professor of neuroscience at George Mason University in Fairfax, Va., and director of the Krasnow Institute, cautioned in an interview with UPI.

He said since there is no cure and limited treatment, telling a person they have Alzheimer's when there is no cure means that person must knowingly live with it for a longer period of time -- while they still have most of their cognitive capabilities -- rather than being told when the disease has progressed to the point they are not able to fully comprehend.

That does not mean, however, a blood test would not be useful in understanding what is taking place in the brain, he added. "If we assume what's happening in the blood is happening in the brain," he said, "that's a big red flag that things aren't going well."


'"/>




Related medicine news :

1. Recommendations for Treatment of Blood Pressue
2. Blood Cells Capable of Regenerating Liver
3. Blood clots likely in long travel
4. Hemochromatosis Patients Blood is Safe
5. Blood transfusions beneficial after heart attacks
6. Blood Pressure Drug may slow wasting in burn victims
7. Levels Of Blood Proteins May Help Heart Disease Care
8. Blood test may identify ovarian cancer
9. A Blood test for suicide risk?
10. Blood Pressure Drugs maintain muscle strength
11. Blood test diagnoses heart failure in short time
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/23/2017)... ... August 23, 2017 , ... ... made the 2017 Inc. 5000 with a three-year sales growth of 49 ... private companies and comprises the most comprehensive look at America’s independent entrepreneurs. This ...
(Date:8/23/2017)... Arizona (PRWEB) , ... August 23, 2017 , ... ... in the top 20% of hospitals nationally that earned the designation of High ... list. An overall rating of high performing indicates a hospital was significantly better than ...
(Date:8/23/2017)... ... 23, 2017 , ... MobilityWorks ®, the nation's largest ... 2017 Inc. 500|5000, an exclusive ranking of America’s fastest-growing private companies. MobilityWorks (aka ... marking the twelfth year that the company has been included on the list. ...
(Date:8/23/2017)... ... 2017 , ... Virsys12, a Salesforce Gold Consulting Partner, continues ... of Kevin Keelan as a Senior Account Executive, based in the Denver, Colorado ... working with Virsys12 senior leadership to extend and develop the firm’s client portfolio ...
(Date:8/23/2017)... (PRWEB) , ... August 23, 2017 , ... ... of the American Academy of Orthopaedic Surgeons , points out that therapeutic ... suffering from pain or injury. According to the report, a wider scope of ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... 15, 2017   Mostyn Law and Gulf Coast Regional ... Texas . The Mostyn Law family has had ... That is why Mostyn Law is partnering with Gulf ... show its appreciation. Blood supplies are running low. Gulf ... of hospital needs in August. That is why the blood center ...
(Date:8/15/2017)... , Aug. 15, 2017  Axium Pharmaceuticals Inc., the creator of the ... be in the beginning stages of an IPO. ... medications with the average cost of a prescription epilepsy drug being $450.00-$1200.00 ... AXIUM PHARMACEUTICALS, ... Another staggering figure is the fact that Americans ...
(Date:8/15/2017)...  AOTI Inc. announced today that its fully owned ... a New York City Office in Yonkers, New York ... Wound Oxygen (TWO 2 ) homecare therapy. This new East Coast ... Care (ACHC) under the company,s DMEPOS accreditation for Home/Durable Medical Equipment ... Advanced Oxygen Therapy ...
Breaking Medicine Technology: